Beta Bionics (BBNX) News Today $10.61 +0.50 (+4.95%) Closing price 04:00 PM EasternExtended Trading$10.93 +0.32 (+2.98%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BBNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in DevelopmentMay 21 at 4:04 PM | globenewswire.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 20 at 4:19 AM | americanbankingnews.comBeta Bionics (NASDAQ:BBNX) Price Target Lowered to $11.00 at Bank of AmericaMay 19 at 3:25 AM | americanbankingnews.comBeta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump PlansMay 13, 2026 | marketbeat.comBeta Bionics (BBNX) price target decreased by 11.15% to 20.99April 28, 2026 | msn.comBeta Bionics to Present at the Bank of America Securities Health Care ConferenceApril 27, 2026 | globenewswire.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by AnalystsApril 25, 2026 | marketbeat.comBeta Bionics Earnings Call Highlights Growth And RisksApril 22, 2026 | tipranks.comBeta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceApril 22, 2026 | finanznachrichten.deBeta Bionics Inc (BBNX) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ...April 22, 2026 | finance.yahoo.comBeta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5%April 22, 2026 | seekingalpha.comBeta Bionics (NASDAQ:BBNX) Price Target Cut to $24.00 by Analysts at Leerink PartnersApril 22, 2026 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Gap Up on Strong EarningsApril 22, 2026 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Given New $20.00 Price Target at Stifel NicolausApril 22, 2026 | marketbeat.comBeta Bionics, Inc. (BBNX) Q1 2026 Earnings Call TranscriptApril 21, 2026 | seekingalpha.comBeta Bionics, Inc. 2026 Q1 - Results - Earnings Call PresentationApril 21, 2026 | seekingalpha.comBeta Bionics Q1 Earnings Call HighlightsApril 21, 2026 | marketbeat.comBeta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceApril 21, 2026 | globenewswire.comBeta Bionics Inc (BBNX) Q1 2026 Earnings Report Preview: What To ExpectApril 20, 2026 | finance.yahoo.comBeta Bionics, Inc. Investigated by the Portnoy Law FirmApril 14, 2026 | globenewswire.comGoldman Sachs Keeps Their Buy Rating on Beta Bionics, Inc. (BBNX)April 10, 2026 | theglobeandmail.comBeta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes CareMarch 31, 2026 | theglobeandmail.comBeta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026March 30, 2026 | globenewswire.comBBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsMarch 28, 2026 | prnewswire.comBBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsMarch 24, 2026 | globenewswire.comSHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX)March 17, 2026 | prnewswire.comBeta Bionics (NASDAQ:BBNX) Insider Mark Hopman Sells 856 SharesMarch 17, 2026 | insidertrades.comBeta Bionics: Speculative Appeal After An Eventful Start To The YearMarch 13, 2026 | seekingalpha.comBBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta BionicsMarch 13, 2026 | globenewswire.comINVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsMarch 12, 2026 | prnewswire.comBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta BionicsMarch 6, 2026 | businesswire.comINVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsMarch 5, 2026 | prnewswire.comBeta Bionics (NASDAQ:BBNX) Insider Sells $10,308.24 in StockMarch 4, 2026 | insidertrades.comBeta Bionics Insiders Quietly Cash Out in a Wave of Executive Stock SalesMarch 3, 2026 | tipranks.comBBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsMarch 3, 2026 | globenewswire.comBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsFebruary 28, 2026 | prnewswire.comBeta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover LossesFebruary 25, 2026 | globenewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsFebruary 21, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNXFebruary 19, 2026 | prnewswire.comBeta Bionics to Present at the TD Cowen 46th Annual Health Care ConferenceFebruary 19, 2026 | globenewswire.comBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsFebruary 19, 2026 | globenewswire.comBeta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026February 18, 2026 | finanznachrichten.deBeta Bionics, Inc. 2025 Q4 - Results - Earnings Call PresentationFebruary 18, 2026 | seekingalpha.comBeta Bionics outlines $130M–$135M 2026 revenue target while expanding sales force and pharmacy channelFebruary 18, 2026 | seekingalpha.comBeta Bionics Inc (BBNX) Q4 2025 Earnings Call Highlights: Record Growth Amid Regulatory ChallengesFebruary 18, 2026 | uk.finance.yahoo.comBeta Bionics, Inc. (BBNX) Q4 2025 Earnings Call TranscriptFebruary 18, 2026 | seekingalpha.comHold Rating Maintained as In-Line Results and Improving Margins Offset Near-Term Prescription HeadwindsFebruary 17, 2026 | tipranks.comBeta Bionics (BBNX) Q4 2025 Earnings TranscriptFebruary 17, 2026 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNXFebruary 17, 2026 | globenewswire.comBeta Bionics, Inc. Reports Strong Q4 and Full Year 2025 Results with Significant Growth in Net Sales and Patient Starts, Provides 2026 GuidanceFebruary 17, 2026 | quiverquant.comQ Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBNX Media Mentions By Week BBNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBNX News Sentiment▼-0.450.40▲Average Medical News Sentiment BBNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBNX Articles This Week▼45▲BBNX Articles Average Week Get the Latest News and Ratings for BBNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Beta Bionics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Pulse Biosciences News Today PROCEPT BioRobotics News Today Enovis News Today National Vision News Today Cadre News Today Avanos Medical News Today Kestra Medical Technologies News Today Inspire Medical Systems News Today Artivion News Today iRadimed News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBNX) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
